Inventor
VIFIAN WALTER
CH17 patents
⚠️ This page may combine multiple inventors who share the name “VIFIAN WALTER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
8 patentsUS9751870B2Sep 5, 2017
Oxytocin receptor agonists for the treatment of CNS diseases
HOFFMANN LA ROCHE5 citations73
US10246468B2Apr 2, 2019
BACE1 inhibitors
HOFFMANN LA ROCHE3 citations72
US9540397B2Jan 10, 2017
BACE1 inhibitors
HOFFMANN LA ROCHE2 citations71
US7470684B2Dec 30, 2008
Spiropiperidine derivatives as NK3 antagonists
HOFFMANN LA ROCHE6 citations60
US11440915B2Sep 13, 2022
Triazolo-azepine derivatives
HOFFMANN LA ROCHE1 citations58
US11414420B2Aug 16, 2022
Pyrimidine derivatives
HOFFMANN LA ROCHE0 citations58
US10696691B2Jun 30, 2020
BACE1 inhibitors
HOFFMANN LA ROCHE0 citations51
US9346786B2May 24, 2016
Pyrrolidine compounds
HOFFMANN LA ROCHE0 citations41
KNUST HENNER
5 patentsUS8618303B2Dec 31, 2013
Pyrrolidine derivatives
KNUST HENNER4 citations62
US8324250B2Dec 4, 2012
Piperidine derivatives as NK3 receptor antagonists
KNUST HENNER1 citations51
US8324248B2Dec 4, 2012
Piperidine derivatives as NK3 receptor antagonists
KNUST HENNER0 citations51
US9226916B2Jan 5, 2016
Pyrrolidine derivatives
KNUST HENNER0 citations41
US8318749B2Nov 27, 2012
Quinazoline derivatives as NK3 receptor antagonists
KNUST HENNER0 citations41
GRIFFIOEN GERARD
2 patentsUS9023852B2May 5, 2015
1, 2, 4-thiadiazol-5-ylpiperazine derivatives useful in the treatment of neurodegenerative diseases
GRIFFIOEN GERARD3 citations60
US9187440B2Nov 17, 2015
Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease
GRIFFIOEN GERARD1 citations50